SightGlass Vision Shares Latest Diffusion Optics Technology™Data at ARVO 2024, Affirming Myopia Management Performance

Thursday, May 2 2024 | 10 h 17 min | News

Myopia management innovator SightGlass Vision will present new data surrounding its Diffusion Optics Technology™ (DOT 02) spectacle lenses from...

Read More

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

Thursday, February 22 2024 | 08 h 32 min | News

SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to...

Read More

SightGlass Vision Presents New Data at Academy ’23

Tuesday, October 10 2023 | 10 h 13 min | News, Press Release

Findings from three SightGlass Vision Diffusion Optics Technology™ (DOT 02) spectacle lenses studies will take center stage at the American...

Read More

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

Friday, September 22 2023 | 14 h 03 min | News, Press Release

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 02) spectacle lenses...

Read More

SightGlass Vision Reports Positive Four-Year Clinical Trial Outcomes for Myopia Control DOT Spectacle Lenses

Thursday, September 7 2023 | 12 h 32 min | News, Press Release

SightGlass Vision reported positive four-year outcomes from its pivotal CYPRESS study extension, which is evaluating the myopia control performance...

Read More